bronchial asthma
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Object: stable asthmatic patients Control: patients undergoing routine chest CT for small nodules or small gland glass opacities in peripheral lung (early lung cancer and atypical adenomatous hyperplasia) without airway disease such as asthma
Exclusion criteria
Exclusion criteria: If patients meet the following criteria, they are excluded. Patients who i. have respiratory tract infection or other respiratory disease within 4 weeks prior to enrollment ii. have asthma attacks within 4 weeks prior to enrollment iii. use anti-allergy drugs or inhaled anticholinergic drugs within 2 weeks prior to enrollment iv. use systemic corticosteroids within 4 weeks prior to enrollment v. currently smoke, had smoking history with 5 pack-years or more, or had quitted smoking within 6 months prior to the enrollment vi. prepare for pregnancy, in pregnancy or breast-feeding vii. unsuitable for the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The correlation between the concentration of sputum supernatant and serum RELM-beta and the index of airway wall thickness on chest CT in bronchial asthma | — |
Countries
Japan
Contacts
Nagoya City University Dept of Respiratory Medicine, Allergy and Clinical Immunology